In the BioHarmony Drug Report Database
Amantadine
Gocovri, Osmolex Er, Symmetrel (amantadine) is a small molecule pharmaceutical. Amantadine was first approved as Gocovri on 1982-01-01. It is used to treat drug-induced akathisia, drug-induced dyskinesia, dystonia, human influenza, and parkinson disease amongst others in the USA. It is known to target glutamate receptor ionotropic, NMDA 2A, glutamate receptor ionotropic, NMDA 2B, glutamate receptor ionotropic, NMDA 2C, and glutamate receptor ionotropic, NMDA 2D. Amantadine hydrochloride’s patents are valid until 2038-08-23 (FDA).
Trade Name
|
Gocovri, Osmolex Er, Symmetrel |
|---|---|
Common Name
|
amantadine |
ChEMBL ID
|
CHEMBL660 |
Indication
|
drug-induced akathisia, drug-induced dyskinesia, dystonia, human influenza, parkinson disease, secondary parkinson disease |
Drug Class
|
Antivirals/antiparkinsonians (adamantane derivatives) |
Image (chem structure or protein)